InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,240.03
(
1.04%
)
US TECH 100
17,466.00
(
0.29%
)
Dow Jones
38,997.66
(
0.76%
)
Brent Oil
76.49
(
0.61%
)
Bitcoin
56,806.62
(
1.35%
)
Post# of 252797
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

WID

Send PM Follow Ignore
Followers 1
Posts 476
Boards Moderated 0
Alias Born 03/29/2007

WID

Re: poorgradstudent post# 185212

Monday, 12/29/2014 11:55:51 AM

Monday, December 29, 2014 11:55:51 AM

Post# of 252797
Poorgrad, According to you, FDA panel might make a mistake to grant CLDN the Breakthrough Designation Therapy without looking at the info you presented?

I doubt that the company mislead the FDA on the CUPID1 data or the FDA shortsighted on the info you mentioned.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up